Affiliation:
1. Department of Bariatric Surgery The First Affiliated Hospital of Jinan University Guangzhou China
2. Department of Gastrointestinal Surgery Shenzhen Second People's Hospital Shenzhen China
Abstract
AbstractWe explored the role and mechanism of circular RNAcircNRD1 in gastric cancer (GC) progression, aiming to identify new bio‐markers for the treatment and prognosis of GC patients. The RNA expression was examined by reverse transcription‐quantitative polymerase chain reaction. Cell proliferation, migration and invasion were analyzed by 3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide (MTT) assay, 5‐ethynyl‐2'‐deoxyuridine (EdU) incorporation assay, scratch assay and transwell assay. Western blot assay was conducted for protein expression measurement. Dual‐luciferase reporter, RNA immunoprecipitation, and RNA pull‐down assays were conducted to verify the interaction between microRNA‐421 (miR‐421) and circNRD1 or THAP domain containing 11 (THAP11). Xenograft tumor model was established to perform in vivo experiments. CircNRD1 was notably downregulated in GC tissues and cell lines. Additionally, decreased circNRD1 level was closely associated with advanced tumor stage and dismal prognosis in GC patients. CircNRD1 overexpression suppressed the proliferation and metastasis of GC cells. CircNRD1 acted as a molecular sponge for miR‐421 in GC cells, and the antitumor impacts of circNRD1 overexpression in GC cells could be alleviated by miR‐421 overexpression. miR‐421 directly targeted THAP11, and circNRD1 could up‐regulate THAP11 expression in GC cells through sponging miR‐421. THAP11 knockdown reversed circNRD1 overexpression‐induced tumor suppressing effects in GC cells. CircNRD1 overexpression significantly blocked tumor growth in vivo. CircNRD1 suppressed the proliferation and metastasis of GC cells in vitro and blocked tumor growth in vivo via modulating miR‐421/THAP11 axis.